Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Shanghai Synergy Pharmaceutical Sciences, Zhejiang Huahai Pharmaceutical present BRD4 inhibitors

Oct. 27, 2020

ENA 2020: Progress in cancer research can come one mouse at a time, study suggests

Oct. 27, 2020

Shanghai Ringene Biopharma describes new STAT3 inhibitors

Oct. 27, 2020

Olema and Novartis to evaluate OP-1250 in combination therapies

Oct. 27, 2020

KRAS G12C: Adagrasib holds its own at ENA 2020

Oct. 26, 2020

LIDDS' NZ-TLR9 demonstrates antitumoral effect in mouse tumor models

Oct. 26, 2020

Venenum Biodesign synthesizes TREX1 inhibitors

Oct. 26, 2020

Anadolu Ueniversitesi discloses new compounds for cancer

Oct. 26, 2020

First patient dosed in phase Ib/II study of dubermatinib plus decitabine in AML

Oct. 26, 2020

New phase II trial investigates PT-112 for metastatic CRPC

Oct. 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...